<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJIC</journal-id><journal-title-group><journal-title>Open Journal of Inorganic Chemistry</journal-title></journal-title-group><issn pub-type="epub">2161-7406</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojic.2016.64017</article-id><article-id pub-id-type="publisher-id">OJIC-71250</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Chemistry&amp;Materials Science</subject></subj-group></article-categories><title-group><article-title>
 
 
  Theoretical Insights Elucidate Novel Active Phosphonate Esters—Cephalosporin Antibiotics’ Intermediate
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Youmin</surname><given-names>Sun</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Huixue</surname><given-names>Ren</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Xiaofeng</surname><given-names>Wei</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Guiqin</surname><given-names>Zhang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>School of Municipal and Environmental Engineering, Shandong Jianzhu University, Jinan, China</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>ymsun@sdjzu.edu.cn(YS)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>17</day><month>10</month><year>2016</year></pub-date><volume>06</volume><issue>04</issue><fpage>219</fpage><lpage>228</lpage><history><date date-type="received"><day>August</day>	<month>15,</month>	<year>2016</year></date><date date-type="rev-recd"><day>Accepted:</day>	<month>October</month>	<year>14,</year>	</date><date date-type="accepted"><day>October</day>	<month>17,</month>	<year>2016</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Theoretical insights elucidate a series of active phosphonate esters application in preparation of Cephalosporin antibiotics’ intermediate. The B3LYP/6-311+G(d,p) method was employed to obtain the stable equilibrium geometries including comparing to the AE-active ester. It was found that the Ethyl-aminothiazoly Loximate (AT) molecule fragment is almost planar sheet, but it is almost perpendicular to the plane of phosphoryl ester. Moreover, the calculated Mulliken atomic charge distribution and frontier molecular orbital analysis of these esters showed that the amino N atom connected to the Thiazole ring of the AT had the maximum negative charge, which suggested that this area had high molecular activity. The value of ΔEL-H was energy gap between EHOMO and ELUMO and indicated that compound 6a had high reaction activity. The theory calculation results can explain the reaction mechanism well and predict that the novel active phosphonate ester has a hopeful application prospect in preparation of Cephalosporin antibiotics’ intermediate.
 
</p></abstract><kwd-group><kwd>Active Phosphonate Ester</kwd><kwd> Activity</kwd><kwd> Density Functional Theory</kwd><kwd> Molecular Orbital</kwd><kwd> Cephalosporin Antibiotics’ Intermediate</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Cephalosporins, which contain thiazolidine-β-lactam rings, are isolated from fungi Cephalosporium analogous to Penicillium. Natural cephalosporins comprise cephalosporin C, N, and P [<xref ref-type="bibr" rid="scirp.71250-ref1">1</xref>] - [<xref ref-type="bibr" rid="scirp.71250-ref4">4</xref>] . There are many relevant antibiotics, including cefotaxime, ceftriaxone, and ceftazidime, among others [<xref ref-type="bibr" rid="scirp.71250-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.71250-ref6">6</xref>] . The typical core structure of cephalosporins is shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>. The routine synthetic procedure was first with 7-</p><fig id="fig1"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref></label><caption><title> Structure of cephalosporin</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1310151x2.png"/></fig><p>aminocephalosporanic acid (7-ACA) as raw material. To increase the yields of the antibiotics synthesis by elevating the activation efficiency of acylation of the amino group in 7-ACA, various types of acylating agents have been developed, of which carboxylic thiol esters, pyridinecarboxylic acid esters, and carboxylic trinitrophenyl esters are the most representative reagents [<xref ref-type="bibr" rid="scirp.71250-ref7">7</xref>] . Currently, third-generation cephalosporins are normally synthesized by using 2-(2-amino-4-thiazolyl)-2-methoxyiminoacetic thiobenzothiazole ester (popular name: AE-active ester; <xref ref-type="fig" rid="fig2">Figure 2</xref>) derived from 2-(2-aminothia- zole-4-yl)-2-methoxyiminoacetic acid (ATMA) and 2,2’-dibenzothiazolyl disulfide (popular name: accelerator DM) (<xref ref-type="fig" rid="fig2">Figure 2</xref>) [<xref ref-type="bibr" rid="scirp.71250-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.71250-ref9">9</xref>] . In this reaction route, the raw material DM is often excessive and remains in the preparation of AE-active ester and is toxic for animals, which is stipulated the residual amount in US Food and Drug Administration and some European countries in cephalosporins. Hence, developing novel active esters without using accelerator DM is imperative [<xref ref-type="bibr" rid="scirp.71250-ref10">10</xref>] - [<xref ref-type="bibr" rid="scirp.71250-ref12">12</xref>] . Phosphphate is found to synthesis active phosphonate esters that are beneficial to improving the security of administering cephalosporin drugs [<xref ref-type="bibr" rid="scirp.71250-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.71250-ref14">14</xref>] . Our research group has reported the detail synthetic route in the previous articles [<xref ref-type="bibr" rid="scirp.71250-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.71250-ref16">16</xref>] . It is shown that the novel phosphonate esters (<xref ref-type="fig" rid="fig3">Figure 3</xref>) have high activity and are superior to AE-active ester, which are commonly applied in modifying second-generation and third-generation cephalosorins [<xref ref-type="bibr" rid="scirp.71250-ref17">17</xref>] .</p><p>According to a series of experimental synthesized active phosphonate esters, the yield of ceftriaxone with different active ester increases compared with commonly used benzothiazole AE-active ester [<xref ref-type="bibr" rid="scirp.71250-ref15">15</xref>] . Among these esters, 2-(2-aminothiazol-5-yl)-2-(me- thoxyimino)acetic(O,O-bis(4-nitrophenyl)phosphorothioic)anh-ydride (6a) is most active in the synthesis of ceftriaxone. In order to elucidate novel active phosphonate esters, a quantum chemistry calculation study was used. This paper is focused on the theoretical elucidation active phosphonate esters of Cephalosporin antibiotics’ intermediate. We mainly study the properties of the compounds 6a, 6b, 1a and 1b comparing to the AE-active ester that is now accounting for 80% of these commercially available reagents.</p></sec><sec id="s2"><title>2. Experimental</title><p>The calculation procedures are as follows. The computational accuracy, feasibility and economical computational time are considered when choosing the computational levels and basis sets. The geometrical parameters are optimized at the B3LYP level with a standard 6-311+G(d, p) [<xref ref-type="bibr" rid="scirp.71250-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.71250-ref19">19</xref>] basis set. The B3LYP/6-311+G(d,p) is proved to be an outstanding method for prediction of thermochemical kinetics and vibrational frequencies</p><fig-group id="fig2"><label><xref ref-type="fig" rid="fig2">Figure 2</xref></label><caption><title> Synthetic route of AE-active ester.</title></caption><fig id ="fig2_1"><label> (DM)</label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1310151x3.png"/></fig><fig id ="fig2_2"><label>(AE-active ester)</label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1310151x4.png"/></fig></fig-group><fig-group id="fig3"><label><xref ref-type="fig" rid="fig3">Figure 3</xref></label><caption><title> Structures of active phosphonate esters.</title></caption><fig id ="fig3_1"><label></label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1310151x5.png"/></fig></fig-group><p>of Organic Compounds. All structures of active phosphonate esters have been located on the potential energy surface (PES) by performing full geometry optimization without any symmetry restriction, and their natures including local minima have been identified by performing frequency calculations at the same level, from which the zero point energies (ZPEs) have also been derived. All of the quantum chemical calculations were performed in the framework of DFT using Gaussian by the Gaussian 03 program [<xref ref-type="bibr" rid="scirp.71250-ref20">20</xref>] .</p></sec><sec id="s3"><title>3. Results and Discussion</title><sec id="s3_1"><title>3.1. Molecular Geometry</title><p>Through a multi-step series of simulation optimization, stable equilibrium geometries of the active ester (1a, 1b, 6a, 6b) were obtained and shown in <xref ref-type="fig" rid="fig4">Figure 4</xref>. The ethyl- aminothiazolyloximate (AT) molecular fragment was almost planar sheet, with the plane of phosphoryl ester having the dihedral angle C11-O15-P17-O21 67˚. In addition, the steric structures of phosphoryl ester with sulfur and oxygen in P-S and P-O bonds are similar with the same R substituent. Moreover, with the change of R substituent, the ethyl-aminothiazolyloximate (AT) molecular fragment is almost no change. When R is a 4-NO<sub>2</sub>-C<sub>6</sub>H<sub>4 </sub>substituent, two substituent benzene rings were almost vertical due to steric effect.</p><fig-group id="fig4"><label><xref ref-type="fig" rid="fig4">Figure 4</xref></label><caption><title> Optimized structures of active phosphonate ester at the B3LYP/6-311+G(d,p) level.</title></caption><fig id ="fig4_1"><label></label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1310151x7.png"/></fig><fig id ="fig4_2"><label></label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1310151x6.png"/></fig><fig id ="fig4_3"><label></label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1310151x8.png"/></fig><fig id ="fig4_4"><label></label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1310151x9.png"/></fig></fig-group><p>In order to compare the structural difference, AE-active ester was also optimized at the B3LYP/6-311+G(d,p) level and the molecular geometry was shown in <xref ref-type="fig" rid="fig5">Figure 5</xref>. AE-active ester is obtained by the thio-esterification condensation reaction of AT and DM (see <xref ref-type="fig" rid="fig2">Figure 2</xref>). The equilibrium molecular geometry is the vertical connection between AT molecular fragment and M (2-mercapto benzothiazole) molecular fragment. The dihedral angle of C6-C9-S13-C14 is 87˚, which is larger than that in the active phosphonate ester. At the connection place, the carboxyl C atom of AT connected with the thiol group S atom of M.</p></sec><sec id="s3_2"><title>3.2. Charge Distribution</title><p><xref ref-type="table" rid="table1">Table 1</xref> gives the calculated mulliken atomic charge distribution of the active phosphonate ester core. All the N and O atoms have negative charges concentrated in AT molecular fragments. Moreover, the amino N (8) atom connected to the thiazole ring of AT</p><fig id="fig5"  position="float"><label><xref ref-type="fig" rid="fig5">Figure 5</xref></label><caption><title> Optimized structures of AE-active ester at the B3LYP/6-311+G(d,p) level</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1310151x16.png"/></fig><p>had the maximum negative charge. Experimentally synthesis of ceftriaxone using the phosphonate active esters with 7-ACA, the C11-O15 bond is broken. Seen from <xref ref-type="table" rid="table1">Table 1</xref>, it is found that the charge on C16 atom has largest negative charge, −1.461412 for compound 6a and −1.127062 for compound 6b. This results agree with experimental phenomenon that the element X connects to the phosphorus is S, activity of phosphonate ester is high.</p><p>For AE-active ester, the calculated Mulliken atomic charges were listed in <xref ref-type="table" rid="table2">Table 2</xref>. Similar to active phosphonate ester, the N and O atoms have negative charge in the AT the molecular fragment. Linked to O, and N atoms such as C atoms C2, C6, C17 distribute the main positive charge, and the C atoms are connected to the H atoms mainly distribute negative charge. When to synthesize cephalosporin antibiotics with AE-active ester, the ester bond C9-S13 was broken and the M molecular fragment is removed, and then connected with the β-lactam in the 7-ACA molecule. The C atom accepts the electrons offered by ?NH 2 as electron acceptor. Seen from <xref ref-type="table" rid="table2">Table 2</xref>, it is found that the charge on C9 atom is −0.36768 and smaller than that on C16 atom of compound 6a. Hence, the high activity of this active ester can be attributed to the following reasons.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Calculated Mulliken atomic charges of active phosphonate ester for compounds 1a, 1b, 6a and 6b, respectively</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >atom</th><th align="center" valign="middle" >1a</th><th align="center" valign="middle" >1b</th><th align="center" valign="middle" >6a</th><th align="center" valign="middle" >6b</th></tr></thead><tr><td align="center" valign="middle" >S1</td><td align="center" valign="middle" >−0.046261</td><td align="center" valign="middle" >−0.088404</td><td align="center" valign="middle" >−0.098049</td><td align="center" valign="middle" >−0.089855</td></tr><tr><td align="center" valign="middle" >C2</td><td align="center" valign="middle" >−0.182908</td><td align="center" valign="middle" >−0.128987</td><td align="center" valign="middle" >−0.276021</td><td align="center" valign="middle" >−0.280297</td></tr><tr><td align="center" valign="middle" >C3</td><td align="center" valign="middle" >0.918978</td><td align="center" valign="middle" >0.711214</td><td align="center" valign="middle" >1.007407</td><td align="center" valign="middle" >0.931253</td></tr><tr><td align="center" valign="middle" >N4</td><td align="center" valign="middle" >−0.080687</td><td align="center" valign="middle" >−0.090859</td><td align="center" valign="middle" >−0.088637</td><td align="center" valign="middle" >−0.083803</td></tr><tr><td align="center" valign="middle" >N5</td><td align="center" valign="middle" >−0.300217</td><td align="center" valign="middle" >−0.303431</td><td align="center" valign="middle" >−0.289096</td><td align="center" valign="middle" >−0.288201</td></tr><tr><td align="center" valign="middle" >C6</td><td align="center" valign="middle" >0.108411</td><td align="center" valign="middle" >−0.058120</td><td align="center" valign="middle" >0.222995</td><td align="center" valign="middle" >0.299641</td></tr><tr><td align="center" valign="middle" >C7</td><td align="center" valign="middle" >−0.422135</td><td align="center" valign="middle" >−0.130257</td><td align="center" valign="middle" >−0.271779</td><td align="center" valign="middle" >−0.353063</td></tr><tr><td align="center" valign="middle" >N10</td><td align="center" valign="middle" >−0.345016</td><td align="center" valign="middle" >−0.259018</td><td align="center" valign="middle" >−0.245743</td><td align="center" valign="middle" >−0.283129</td></tr><tr><td align="center" valign="middle" >C11</td><td align="center" valign="middle" >−0.375505</td><td align="center" valign="middle" >−0.512285</td><td align="center" valign="middle" >−1.461412</td><td align="center" valign="middle" >−1.127062</td></tr><tr><td align="center" valign="middle" >O13</td><td align="center" valign="middle" >0.117513</td><td align="center" valign="middle" >0.048156</td><td align="center" valign="middle" >0.115018</td><td align="center" valign="middle" >0.106771</td></tr><tr><td align="center" valign="middle" >O14</td><td align="center" valign="middle" >−0.140705</td><td align="center" valign="middle" >−0.139254</td><td align="center" valign="middle" >0.054591</td><td align="center" valign="middle" >0.024536</td></tr><tr><td align="center" valign="middle" >O15</td><td align="center" valign="middle" >−0.140772</td><td align="center" valign="middle" >−0.173887</td><td align="center" valign="middle" >0.266653</td><td align="center" valign="middle" >0.218750</td></tr><tr><td align="center" valign="middle" >C16</td><td align="center" valign="middle" >−0.244536</td><td align="center" valign="middle" >−0.231232</td><td align="center" valign="middle" >−0.229991</td><td align="center" valign="middle" >−0.229614</td></tr><tr><td align="center" valign="middle" >P17</td><td align="center" valign="middle" >−0.310921</td><td align="center" valign="middle" >0.166952</td><td align="center" valign="middle" >−0.117455</td><td align="center" valign="middle" >−0.045287</td></tr><tr><td align="center" valign="middle" >O21</td><td align="center" valign="middle" >−0.040990</td><td align="center" valign="middle" >−0.163310</td><td align="center" valign="middle" >0.074834</td><td align="center" valign="middle" >−0.066869</td></tr><tr><td align="center" valign="middle" >O22</td><td align="center" valign="middle" >−0.169908</td><td align="center" valign="middle" >−0.250323</td><td align="center" valign="middle" >−0.000435</td><td align="center" valign="middle" >−0.046130</td></tr><tr><td align="center" valign="middle" >S23</td><td align="center" valign="middle" >0.042225</td><td align="center" valign="middle" >0.031299</td><td align="center" valign="middle" >0.130594</td><td align="center" valign="middle" >0.032494</td></tr><tr><td align="center" valign="middle" >C24</td><td align="center" valign="middle" >−0.339169</td><td align="center" valign="middle" >−0.297619</td><td align="center" valign="middle" >0.177783</td><td align="center" valign="middle" >−0.239864</td></tr><tr><td align="center" valign="middle" >C25</td><td align="center" valign="middle" >−0.212809</td><td align="center" valign="middle" >−0.294822</td><td align="center" valign="middle" >0.074142</td><td align="center" valign="middle" >−0.405757</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Calculated Mulliken atomic charges of AE-active ester</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >atom</th><th align="center" valign="middle" >charge</th><th align="center" valign="middle" >atom</th><th align="center" valign="middle" >charge</th><th align="center" valign="middle" >atom</th><th align="center" valign="middle" >charge</th></tr></thead><tr><td align="center" valign="middle" >N1</td><td align="center" valign="middle" >0.52138</td><td align="center" valign="middle" >C9</td><td align="center" valign="middle" >−0.36768</td><td align="center" valign="middle" >C17</td><td align="center" valign="middle" >0.11831</td></tr><tr><td align="center" valign="middle" >C2</td><td align="center" valign="middle" >0.25767</td><td align="center" valign="middle" >O10</td><td align="center" valign="middle" >−0.40446</td><td align="center" valign="middle" >C18</td><td align="center" valign="middle" >−0.24109</td></tr><tr><td align="center" valign="middle" >C3</td><td align="center" valign="middle" >0.08776</td><td align="center" valign="middle" >C11</td><td align="center" valign="middle" >−0.31759</td><td align="center" valign="middle" >C19</td><td align="center" valign="middle" >−0.22306</td></tr><tr><td align="center" valign="middle" >S4</td><td align="center" valign="middle" >0.38427</td><td align="center" valign="middle" >O12</td><td align="center" valign="middle" >−0.50846</td><td align="center" valign="middle" >C20</td><td align="center" valign="middle" >−0.24186</td></tr><tr><td align="center" valign="middle" >N5</td><td align="center" valign="middle" >−0.85201</td><td align="center" valign="middle" >S13</td><td align="center" valign="middle" >0.37478</td><td align="center" valign="middle" >C21</td><td align="center" valign="middle" >−0.24382</td></tr><tr><td align="center" valign="middle" >C6</td><td align="center" valign="middle" >0.11512</td><td align="center" valign="middle" >C14</td><td align="center" valign="middle" >−0.1338</td><td align="center" valign="middle" >C22</td><td align="center" valign="middle" >0.36768</td></tr><tr><td align="center" valign="middle" >C7</td><td align="center" valign="middle" >−0.43885</td><td align="center" valign="middle" >S15</td><td align="center" valign="middle" >0.44851</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >N8</td><td align="center" valign="middle" >−0.10935</td><td align="center" valign="middle" >N16</td><td align="center" valign="middle" >−0.4584</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>1) Being electronegative, sulfur and oxygen in P-S and P-O bonds are prone to enhancing the electron-withdrawing ability and nucleophilicity of phosphorus-containing groups, thus facilitating the acylation of 7-amino. 2) Nitrophenyl groups are more subject to being removed than other alkyl groups due to large steric space, thereby increasing the synthesis efficiency of ceftriaxone.</p></sec><sec id="s3_3"><title>3.3. Frontier Molecular Orbital Analysis</title><p>According to the molecular orbital theory, the highest occupied orbital (HOMO) and the lowest empty orbital (LUMO) can effectively predict the biological activity site and provide important information for exploring reaction mechanisms. The energy of HOMO, E<sub>HOMO</sub>, associates with molecular ionization potential, can be used as a measure of providing electronic ability of the molecular. The energy of LUMO, E<sub>LUMO</sub>, stands for acceptor ability of the molecular. <xref ref-type="fig" rid="fig6">Figure 6</xref> shows HOMO and LUMO of compounds 1a, 6a and AT-active ester. The frontier molecular orbital analysis shows that the main active part centralizes at the AT molecular fragment, especially at the amido connected with the thiazole ring and it is easy to react while acting with other bio- molecule. Therefore, novel active phosphonate ester 6a still maintains the biological activity site.</p><p><xref ref-type="table" rid="table3">Table 3</xref> shows the energy of molecular frontier orbital in novel active phosphonate ester and AE-active ester. The value of ΔE<sub>L-H</sub> is energy gap between E<sub>HOMO</sub> and E<sub>LUMO</sub>.</p><p>The smaller value corresponds to high reaction activity. Seen the calculated values, the ΔE<sub>L-H</sub> of compound 6a is smallest. The theory calculation can explain the reaction mechanism well.</p></sec></sec><sec id="s4"><title>4. Conclusion</title><p>Density functional theory B3LYP/6-311+G(d,p) method was employed to theoretically elucidate a series of active phosphonate esters application in preparation of Cephalosporin antibiotic’s intermediate. First, the stable equilibrium geometries including comparing to the AE-active ester were obtained. It was found that the Ethyl-aminothiazoly Loximate (AT) molecule fragment is almost planar sheet, but it is almost perpendicular to the plane of phosphoryl ester. Moreover, the calculated Mulliken atomic charge distribution and frontier molecular orbital analysis of these esters showed that the amino N atom connected to the Thiazole ring of the AT had the maximum negative charge, which suggested that this area had high molecular activity. The high activity of 6a active ester can be attributed to the two aspects including large negative charge and steric space. Energy gap between E<sub>HOMO</sub> and E<sub>LUMO</sub>, ΔE<sub>L-H</sub>, indicated also that compound 6a has high reaction activity. The theory calculation results can explain the experimental phenomenon and predict that the novel active phosphonate ester has a hopeful application prospect in preparation of Cephalosporin antibiotics’ intermediate.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Molecular frontier orbital energy (Hartree)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >1a</th><th align="center" valign="middle" >1b</th><th align="center" valign="middle" >6a</th><th align="center" valign="middle" >6b</th><th align="center" valign="middle" >AE- active ester</th></tr></thead><tr><td align="center" valign="middle" >E<sub>HOMO</sub></td><td align="center" valign="middle" >−0.21868</td><td align="center" valign="middle" >−0.21749</td><td align="center" valign="middle" >−0.23256</td><td align="center" valign="middle" >−0.23145</td><td align="center" valign="middle" >−0.21414</td></tr><tr><td align="center" valign="middle" >E<sub>LUMO</sub></td><td align="center" valign="middle" >−0.06676</td><td align="center" valign="middle" >−0.06226</td><td align="center" valign="middle" >−0.11373</td><td align="center" valign="middle" >−0.11158</td><td align="center" valign="middle" >−0.06424</td></tr><tr><td align="center" valign="middle" >ΔE<sub>L−H </sub></td><td align="center" valign="middle" >0.15192</td><td align="center" valign="middle" >0.15523</td><td align="center" valign="middle" >0.11883</td><td align="center" valign="middle" >0.11987</td><td align="center" valign="middle" >0.1505</td></tr></tbody></table></table-wrap><fig-group id="fig6"><label><xref ref-type="fig" rid="fig6">Figure 6</xref></label><caption><title> HOMO (right) and LUMO (left) of phosphonate active ester for 1a (Top), 6a (middle) and AE-active ester (bottom).</title></caption><fig id ="fig6_1"><label></label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1310151x18.png"/></fig><fig id ="fig6_2"><label></label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1310151x17.png"/></fig><fig id ="fig6_3"><label></label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1310151x20.png"/></fig><fig id ="fig6_4"><label></label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1310151x19.png"/></fig><fig id ="fig6_5"><label></label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1310151x22.png"/></fig><fig id ="fig6_6"><label></label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1310151x21.png"/></fig></fig-group></sec><sec id="s5"><title>Acknowledgements</title><p>This work was financially supported by Research Project of Shandong Province Science and Technology Development (No. 2014GSF117002). We also thank International Cooperation Training Project for Outstanding Young Teachers in the Colleges and Universities of Shandong Province.</p></sec><sec id="s6"><title>Cite this paper</title><p>Sun, Y.M., Ren, H.X., Wei, X.F. and Zhang, G.Q. (2016) Theoretical Insights Elucidate Novel Active Phosphonate Esters―Cephalosporin Antibiotics’ Intermediate. Open Journal of Inorganic Chemistry, 6, 219-228. http://dx.doi.org/10.4236/ojic.2016.64017</p></sec></body><back><ref-list><title>References</title><ref id="scirp.71250-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Sánchez-Sancho, F., Perez-Inestrosa, E, Suau, R., Montanez, M.I., Mayorga, C., Torres, M. J., Romano, A. and Blanca, M. (2003) Synthesis, Characterization and Immunochemical Evaluation of Cephalosporin Antigenic Determinants. Journal of Molecular Recognition, 16, 148-156. http://dx.doi.org/10.1002/jmr.621</mixed-citation></ref><ref id="scirp.71250-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Ngo, E.O., LePage, G.R., Thanassi, J.W., Meisler, N. and Nutter, L.M. (1998) Absence of Pyridoxine-5’-Phosphate Oxidase (PNPO) Activity in Neoplastic Cells: Isolation, Characterization, and Expression of PNPO cDNA. Biochemistry, 37, 7741-7748.  
http://dx.doi.org/10.1021/bi972983r</mixed-citation></ref><ref id="scirp.71250-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Aitken, S.M., Lodha, P.H. and Morneau, D.J.K. (2011) The Enzymes of the Transsulfuration Pathways: Active-Site Characterizations. Biochimicaet Biophysica Acta, 1814, 1511-1517.</mixed-citation></ref><ref id="scirp.71250-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Ren, H.X., Ying, H.J., Liu, C., Jia, X.F. and Yang, Y.Z. (2011) Study on the Synthesis of Cefuroxime Acid with a New Phosphoryl Active Ester. Journal of Shandong University (Natural Science), 46, 9-17.</mixed-citation></ref><ref id="scirp.71250-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Ren, H.X., Sun, Y.M., Wu, D.J., Ma, Y.S., Ying, H.J. and Ma, Y. (2014) Design and Synthesis of Novel Active Phosphonate Esters and Their Application in Preparation of Ceftriaxone. Heterocyclic Communications, 20, 155-159.</mixed-citation></ref><ref id="scirp.71250-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Eiga, T., Gombert, A.K., Landes, N., Verhoeven, M.D., Kiel, J.A., Krikken, A.M., Nijland, J.G., Touw, H., Luttik, M.A., van der Toorn, J.C., Driessen, A.J., Bovenberg, R.A., van den Berg, M.A., van der Klei, I.J., Pronk, J.T. and Daran, J.M. (2012) Metabolic Engineering of β-Oxidation in Penicillium chrysogenum for Improved Semi-Synthetic Cephalosporin Biosynthesis. Metabolic Engineering, 14, 437-448.</mixed-citation></ref><ref id="scirp.71250-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Lee, C., Yang, W. and Parr, R.G. (1988) Development of the Colle-Salvetti Correlation Energy Formula into a Functional of the Electron Density. Physical Review B, 37, 785-789.  
http://dx.doi.org/10.1103/PhysRevB.37.785</mixed-citation></ref><ref id="scirp.71250-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Becke, A.D. (1993) A New Mixing of Hartree-Fock and Local Density Functional Theories. The Journal of Chemical Physics, 98, 1372-1377. http://dx.doi.org/10.1063/1.464304</mixed-citation></ref><ref id="scirp.71250-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Frisch, M.J., Trucks, G.W., Schlegel, H.B., Scuseria, G.E., Robb, M.A., Cheeseman, J.R., Zakrzewsk, V.G., Montgomery Jr., J.A., Stratmann, R.E., Burant, J.C., Dapprich, S., Millam, J.M., Daniels, A.D., Kudin, K.N., Strain, M.C., Farkas, O., Tomasi, J., Barone, V., Cossi, M., Cammi, R., Mennucci, B., Pomelli, C., Adamo, C., Clifford, S., Ochterski, J., Petersson, G. A., Ayala, P. Y., Cui, Q., Morokuma, K., Malick, D.K., Rabuck, A.D., Raghavachari, K., Foresman, J.B., Cioslowski, J., Ortiz, J.V., Stefanov, B.B., Liu, G., Liashenko, A., Piskorz, P., Komaromi, I., Gomperts, R., Martin, R.L., Fox, D.J., Keith, T., Al-Laham, M.A., Peng, C.Y., Nanayakkara, A., Gonzalez, C., Challacombe, M., Gill, P.M.W., Johnson, B.G., Chen, W., Wong, M.W., Andres, J.L., Head-Gordon, M., Replogle, E.S. and Pople, J.A. (2004) GAUSSIAN 03, Revision B.04. Gaussian Inc., Wallingford, CT.</mixed-citation></ref><ref id="scirp.71250-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Anacona, J.R. and Rodriguez, A. (2005) Synthesis and Antibacterial Activity of Ceftriaxone Metal Complexes. Transition Metal Chemistry, 30, 897-901.  
http://dx.doi.org/10.1007/s11243-005-6219-0</mixed-citation></ref><ref id="scirp.71250-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Anacona, J.R., RJonathan, G.S. and James, H.L. (2013) Hepatotoxicity of Antibiotics: A Review and Update for the Clinician. Clinics in Liver Disease, 17, 609-642.</mixed-citation></ref><ref id="scirp.71250-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Loris, S., Daniele, T., Ermanno, B. and Francisco, S. (1997) Process for the Preparation of New Intermediates Useful in the Synthesis of Cephalosporins. US Patent 1997, 0982351.</mixed-citation></ref><ref id="scirp.71250-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Debashish, D., Muralikrishna, D., Brijkishore, M. and Pollepeddiln, S. (2005) Novel Intermediates for Synthesis of Cephalosporins and Process for Preparation of such Intermediates. US Patent 2005, 0540770.</mixed-citation></ref><ref id="scirp.71250-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">González, M., Rodríguez, Z., Tolón, B., Rodríguez, J.C., Velez, H., Valdés, B., López, M.A. and Fini, A. (2003) An Alternative Procedure for Preparation of Cefdinir. Il Farmaco, 58, 409-418. http://dx.doi.org/10.1016/S0014-827X(03)00063-6</mixed-citation></ref><ref id="scirp.71250-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Cabri, W., Siviero, E., Daverio, P.L., Cristiano, T., Felisi, C. and Longoni, D. (2003) Process for the Preparation of Beta-Lactam Derivatives. US Patent 2003, 0004336.</mixed-citation></ref><ref id="scirp.71250-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Crisp H.A. and Clayton J.C. (1985) Amorphous Form of Cefuroxime Ester. US Patent No. 4562181.</mixed-citation></ref><ref id="scirp.71250-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">White Herbert, J., Eastlick David, T. and Oughton John, F. (1988) Process for Preparing Sodium Cefuroxime. US Patent No. 4775750.</mixed-citation></ref><ref id="scirp.71250-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Wang, Y., Yu, H.M., Zhang, J., Luo, H. and Shen, Z.Y. (2012) Double Knockout of Lactamase and Cephalosporin Acetyl Esterase Genes from Escherichia coli Reduces Cephalosporin C Decomposition. Journal of Bioscience and Bioengineering, 113, 737-741.  
http://dx.doi.org/10.1016/j.jbiosc.2012.02.003</mixed-citation></ref><ref id="scirp.71250-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Ramos, A.M., Otero, M. and Rodrigues, A.A.E. (2004) Recovery of Vitamin B12 and Cephalosporin C from Aqueous Solutions by Adsorption on Non-Ionic Polymeric Adsorbents. Separation and Purification Technology, 38, 85-98.  
http://dx.doi.org/10.1016/j.seppur.2003.10.008</mixed-citation></ref><ref id="scirp.71250-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Rothstein, J.D., Patel, S., Regan, M.R., Haenggeli, C., Huang, Y.H., Bergles, D.E., Jin, L., Dykes Hoberg, M., Vidensky, S., Chung, D.S., et al. (2005) β-Lactam Antibiotics Offer Neuroprotection by Increasing Glutamate Transporter Expression. Nature, 433, 73-77.  
http://dx.doi.org/10.1038/nature03180</mixed-citation></ref></ref-list></back></article>